BDNF and treatment resistant depression: A randomized, double-blinded clinical trial conducted by Ray-Griffith et al. [21] investigated the effects of ketamine on brain-derived-neurotrophic-factor (BDNF) and treatment outcomes in patients undergoing ECT for TRD.